-PTI The Supreme Court on Thursday directed the chief secretaries of Rajasthan, Haryana, Uttar Pradesh, Andhra Pradesh, Maharashtra and Goa to file their affidavits on compliance of its directions on police reforms and constituting state security commission (SSC). A bench headed by Justice GS Singhvi directed the chief secretaries to respond when the SSC was constituted and how many sittings had taken place and directed them to provide the minutes of the...

-The Telegraph Jamshedpur: A school is a primary lesson in going away from fear and towards power, feel the CRPF. Last year, the paramilitary force reopened a government-run primary school at Thalkobad at Saranda's Manoharpur block in West Singhbhum. Maoists had partially bombed the school in 2004, causing it to become one of the many Maoist-styled cradles in the area that drilled anti-democratic ideologies and taught practical lessons on bombs, guns and...

-Live Mint Vedanta can mine bauxite in Orissa with gram sabha nod, some Karnataka iron ore mines to reopen Two key judgements passed by the Supreme Court on Thursday bode well for India's troubled natural resources sector, keeping alive Vedanta Resources Plc's hopes of mining bauxite in Orissa and promising an alleviation of raw material shortages at steel makers by partly lifting a ban on iron ore mining in Karnataka. The country's top...

-Bloomberg The corpse of Indian farmer Bengali Singh burned to ash atop a blazing funeral pyre on the banks of the river Ganges in 2006. Five years later, the dead man was recorded as being paid by India's $33 billion rural jobs program to dig an irrigation canal in Jharkhand state. Officials in his village and the surrounding region used at least 500 identities, including those of Singh, a disabled child of...

-Live Mint SC rejects Novartis's patent plea for Glivec, says it does not meet any standard of novelty or inventiveness In a landmark judgement, India's apex court rejected Swiss drug maker Novartis AG's legal challenge aimed at securing a patent for blockbuster anti-cancer drug imatinib mesylate, branded Glivec in the country. The verdict, which is seen as a setback to multinational pharmaceutical companies operating in India, may influence a rash of pending disputes...